ANNX three-lens brief
Evidence-based stock research on ANNX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price down 5.26% in the last session — a material single-day move. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Price down 5.26% in the last session — a material single-day move.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- RSI at 28 — technically oversold.
- Underperforming SPY by 18.7pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
ANNX closed at $4.14 (-5.26%) as of 2026-09-11. Market cap: $784.86M. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $15.29 — 269% above current (7 analysts).. Concerns: price down 5.26% in the last session — a material single-day move.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: net income -$55.35M, free cash flow -$115.99M.
Why three lenses on ANNX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ANNXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ANNX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ANNX brief"></iframe>